+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Focal Segmental Glomerulosclerosis (FSGS) Treatment Market - Global Forecast Report 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Chronic Kidney Disease Market Analysis & Forecast 2024-2034: Market By Product (Diagnosis, Treatment; By Route of Administration; By End-user; and By Region - Product Thumbnail Image

Chronic Kidney Disease Market Analysis & Forecast 2024-2034: Market By Product (Diagnosis, Treatment; By Route of Administration; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, and Sales Channel

  • Report
  • April 2022
  • 178 Pages
  • Global
From
Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography - Product Thumbnail Image

Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography

  • Report
  • September 2020
  • 215 Pages
  • Global
From
Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Chronic Kidney Disease Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034 - Product Thumbnail Image

Lupus Nephritis Patient Pool Analysis, Market Size and Market Forecast APAC - 2034

  • Report
  • February 2024
  • 120 Pages
  • Asia Pacific
From
Ornithine Decarboxylase (ODC) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Ornithine Decarboxylase (ODC) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Hepatitis C Virus (HCV) Protease Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis C Virus (HCV) Protease Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Kidney Transplantation Therapeutics Market 2024-2028 - Product Thumbnail Image

Kidney Transplantation Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 171 Pages
  • Global
From
Renal Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 160 Pages
  • Global
From
Chronic Kidney Disease (CKD) Drugs Market 2024-2028 - Product Thumbnail Image

Chronic Kidney Disease (CKD) Drugs Market 2024-2028

  • Report
  • November 2023
  • 184 Pages
  • Global
From
Liver Cirrhosis Therapeutics Market 2024-2028 - Product Thumbnail Image

Liver Cirrhosis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 154 Pages
  • Global
From
Primary Biliary Cholangitis Therapeutics Market 2024-2028 - Product Thumbnail Image

Primary Biliary Cholangitis Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 151 Pages
  • Global
From
End-Stage Renal Disease Market - Growth, Trends, and Forecasts (2023-2028) - Product Thumbnail Image

End-Stage Renal Disease Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 125 Pages
  • Global
From
Hyperkalemia Treatment Market - Growth, Trends, and Forecasts (2023-2028) - Product Thumbnail Image

Hyperkalemia Treatment Market - Growth, Trends, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
Erythropoietin Stimulating Agents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - Product Thumbnail Image

Erythropoietin Stimulating Agents Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • Report
  • February 2021
  • 125 Pages
  • Global
From
Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 98 Pages
  • Global
From
Erythropoietin Stimulating Agents Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Erythropoietin Stimulating Agents Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 172 Pages
  • Global
From
Vietnam Hepatitis Treatment Market, By Region, Competition Forecast & Opportunities, 2019-2029F - Product Thumbnail Image

Vietnam Hepatitis Treatment Market, By Region, Competition Forecast & Opportunities, 2019-2029F

  • Report
  • December 2024
  • 82 Pages
  • Vietnam
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more